A 2025 review published in the International Journal of Molecular Sciences at the Medical University of Warsaw documented five distinct biological pathways the peptide activates
Thats a big part of why the human data has lagged its an economics and incentives story as much as a science story
A decrease in IGF-I levels in AD and VD has been widely documented and it may be involved in the development of neurofibrillary tangles, abnormal amyloid metabolism and aberrant Tau phosphorylation, cognitive loss, neural inflammation, oxidative stress or mitochondrial dysfunction, among others[68, 325]
As a result of oxidation which is a natural process during the process of metabolism, the formation of free radicals, which cause various damages in the organism and initiator of some vital chronic diseases such as cancer and heart diseases, increased the interest in antioxidant compounds that combat them, and studies on this subject mostly focused on the determination of antioxidant activities
Antidepressant effects of ershiwei roudoukou pills and its active ingredient macelignan: multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity